{"product_id":"seeing-inside-your-arteries-the-strengths-and-weaknesses-of-vascular-imaging-for-atherosclerosis","title":"Seeing Inside Your Arteries: The Strengths and Weaknesses of Vascular Imaging for Atherosclerosis","description":"\u003cp\u003eAtherosclerosis is a chronic inflammatory disease that causes fatty plaque to build up inside artery walls, potentially leading to heart attacks, strokes, and poor circulation. This expert review from researchers at Queen's University in Canada examines the strengths and weaknesses of the major imaging tools—ultrasound, computed tomography (CT), and magnetic resonance (MR)—that doctors use to see and measure plaque in the aorta, carotid arteries, coronary arteries, and peripheral blood vessels. The review emphasizes that no single technique is perfect; each varies in invasiveness, cost, resolution, radiation exposure, and vulnerability to image artifacts. The authors also spotlight exciting advances in microvascular imaging, such as contrast-enhanced ultrasound and superb microvascular imaging, which can detect fragile new blood vessels inside plaque that may signal a high risk of rupture.\u003c\/p\u003e\n\n\u003ch1\u003eSeeing Inside Your Arteries: The Strengths and Weaknesses of Vascular Imaging for Atherosclerosis\u003c\/h1\u003e\n\n\u003ch2\u003eTable of Contents\u003c\/h2\u003e\n\u003cul\u003e\n\u003cli\u003e\u003ca href=\"#ddn-key-points\"\u003eKey Points\u003c\/a\u003e\u003c\/li\u003e\n\n  \u003cli\u003e\u003ca href=\"#background\"\u003eBackground: What Is Atherosclerosis and Why Does Imaging Matter?\u003c\/a\u003e\u003c\/li\u003e\n  \u003cli\u003e\u003ca href=\"#methods\"\u003eAbout This Review: How the Research Was Conducted\u003c\/a\u003e\u003c\/li\u003e\n  \u003cli\u003e\u003ca href=\"#techniques\"\u003eThe Imaging Techniques: A Closer Look at the Tools\u003c\/a\u003e\u003c\/li\u003e\n  \u003cli\u003e\u003ca href=\"#key-findings\"\u003eKey Findings: Strengths and Weaknesses of Each Approach\u003c\/a\u003e\u003c\/li\u003e\n  \u003cli\u003e\u003ca href=\"#microvascular\"\u003eMicrovascular Imaging: A New Frontier in Plaque Detection\u003c\/a\u003e\u003c\/li\u003e\n  \u003cli\u003e\u003ca href=\"#clinical-implications\"\u003eClinical Implications: What This Means for Patients\u003c\/a\u003e\u003c\/li\u003e\n  \u003cli\u003e\u003ca href=\"#limitations\"\u003eLimitations of This Research\u003c\/a\u003e\u003c\/li\u003e\n  \u003cli\u003e\u003ca href=\"#recommendations\"\u003eRecommendations for Patients\u003c\/a\u003e\u003c\/li\u003e\n  \u003cli\u003e\u003ca href=\"#ddn-faq\"\u003eFrequently Asked Questions\u003c\/a\u003e\u003c\/li\u003e\n\u003cli\u003e\u003ca href=\"#source\"\u003eSource Information\u003c\/a\u003e\u003c\/li\u003e\n\u003c\/ul\u003e\n\n\u003c!-- ddn:keypoints:start --\u003e\n\u003ch2 id=\"ddn-key-points\"\u003eKey Points\u003c\/h2\u003e\n\u003cul\u003e\n\u003cli\u003eAtherosclerosis is an inflammatory disease causing plaque buildup in arteries, leading to heart attacks, strokes, and poor circulation.\u003c\/li\u003e\n\u003cli\u003eUltrasound, CT, and MRI each have trade-offs in cost, radiation, resolution, invasiveness, and artifacts; no single test is perfect for all situations.\u003c\/li\u003e\n\u003cli\u003eMicrovascular imaging with contrast-enhanced ultrasound or superb microvascular imaging can detect fragile new vessels inside plaque, which may indicate rupture risk.\u003c\/li\u003e\n\u003cli\u003eThe choice of imaging test should be individualized, based on patient risk factors, symptoms, and the clinical question being asked.\u003c\/li\u003e\n\u003cli\u003eImaging cannot replace prevention; managing blood pressure, cholesterol, diabetes, lifestyle, and medications remains the cornerstone of care.\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003c!-- ddn:keypoints:end --\u003e\n\n\n\u003ch2 id=\"background\"\u003eBackground: What Is Atherosclerosis and Why Does Imaging Matter?\u003c\/h2\u003e\n\n\u003cp\u003eAtherosclerosis is not simply a plumbing problem of clogged pipes. It is an \u003cstrong\u003einflammatory disease\u003c\/strong\u003e of the blood vessel wall that develops silently over many years. Fatty deposits, cholesterol, calcium, and immune cells accumulate to form \u003cstrong\u003eplaques\u003c\/strong\u003e that thicken and stiffen the arteries. When these plaques grow or rupture, they can trigger serious and sometimes life-threatening complications.\u003c\/p\u003e\n\n\u003cp\u003eThe review lists three major complications linked to atherosclerosis:\u003c\/p\u003e\n\u003cul\u003e\n  \u003cli\u003e\n\u003cstrong\u003eIschemic heart disease\u003c\/strong\u003e — reduced blood flow to the heart muscle, which can cause chest pain (angina) or heart attacks\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003eStroke\u003c\/strong\u003e — interruption of blood flow to the brain, often caused by plaque rupture in the carotid arteries or arteries feeding the brain\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003ePeripheral vascular disease\u003c\/strong\u003e — narrowing of arteries outside the heart and brain, most often in the legs, causing pain, poor wound healing, and in severe cases, amputation\u003c\/li\u003e\n\u003c\/ul\u003e\n\n\u003cp\u003eBecause atherosclerosis can advance quietly without symptoms, researchers and clinicians rely heavily on \u003cstrong\u003eimaging modalities\u003c\/strong\u003e — the tools that let them \"see\" inside blood vessels. These tools are used for two main purposes: to \u003cstrong\u003eidentify\u003c\/strong\u003e the presence of plaque and, more recently, to \u003cstrong\u003equantify\u003c\/strong\u003e the total burden of disease. Imaging can be performed in several key vascular territories, including the \u003cstrong\u003eaorta\u003c\/strong\u003e (the body's main artery), the \u003cstrong\u003ecarotid arteries\u003c\/strong\u003e in the neck that supply the brain, the \u003cstrong\u003ecoronary arteries\u003c\/strong\u003e that feed the heart muscle, and the \u003cstrong\u003eperipheral vasculature\u003c\/strong\u003e in the limbs and other organs.\u003c\/p\u003e\n\n\u003ch2 id=\"methods\"\u003eAbout This Review: How the Research Was Conducted\u003c\/h2\u003e\n\n\u003cp\u003eThis article is a \u003cstrong\u003ereview paper\u003c\/strong\u003e, not a single clinical trial. Instead of enrolling patients, the authors—Laura E. Mantella, Kiera Liblik, and Dr. Amer M. Johri from the Department of Biomedical and Molecular Sciences and the Cardiovascular Imaging Network at Queen's University in Kingston, Ontario, Canada—systematically examined and synthesized existing published research on vascular imaging of atherosclerosis.\u003c\/p\u003e\n\n\u003cp\u003eThe review was published in the February 2021 edition of the journal \u003cem\u003eAtherosclerosis\u003c\/em\u003e (volume 319, pages 42–50) and became available online in early January 2021. The authors had two central goals:\u003c\/p\u003e\n\u003col\u003e\n  \u003cli\u003eTo review the \u003cstrong\u003estrengths and weaknesses\u003c\/strong\u003e of the various imaging techniques currently used to measure atherosclerotic burden\u003c\/li\u003e\n  \u003cli\u003eTo discuss the \u003cstrong\u003efuture of advanced imaging modalities\u003c\/strong\u003e as potential biomarkers for atherosclerosis — meaning imaging features that could serve as measurable indicators of disease presence, progression, or risk\u003c\/li\u003e\n\u003c\/ol\u003e\n\n\u003cp\u003eBy pulling together evidence across multiple technologies, the review provides what is essentially a \u003cstrong\u003ecomparison guide\u003c\/strong\u003e for researchers and clinicians who need to choose the right imaging tool for the right situation.\u003c\/p\u003e\n\n\u003ch2 id=\"techniques\"\u003eThe Imaging Techniques: A Closer Look at the Tools\u003c\/h2\u003e\n\n\u003cp\u003eThe review focuses on the major non-invasive and minimally invasive imaging technologies used in cardiovascular medicine. These include:\u003c\/p\u003e\n\n\u003cul\u003e\n  \u003cli\u003e\n\u003cstrong\u003eUltrasound\u003c\/strong\u003e — including standard vascular ultrasound, contrast-enhanced ultrasound (CEUS), and a newer technique called superb microvascular imaging (SMI)\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003eComputed tomography (CT)\u003c\/strong\u003e — an X-ray-based technique that creates detailed cross-sectional images, often used to detect and measure calcium and plaque in the coronary arteries\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003eMagnetic resonance imaging (MRI or MR)\u003c\/strong\u003e — a technique using powerful magnetic fields and radio waves to produce high-detail images of soft tissues, including blood vessel walls\u003c\/li\u003e\n\u003c\/ul\u003e\n\n\u003cp\u003eThe authors emphasize that these techniques are not interchangeable. Each one carries its own profile of advantages and disadvantages, and the choice of imaging tool depends on what question is being asked. The key characteristics that differentiate the methods are:\u003c\/p\u003e\n\n\u003cul\u003e\n  \u003cli\u003e\n\u003cstrong\u003eInvasiveness\u003c\/strong\u003e — whether the procedure requires needles, catheters, or contrast agents injected into the body, or whether it is completely non-invasive\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003eCost\u003c\/strong\u003e — the expense of the equipment, the procedure itself, and the expertise required to interpret the images\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003eResolution\u003c\/strong\u003e — the level of detail visible in the images, which affects how accurately plaque can be measured and characterized\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003eRadiation exposure\u003c\/strong\u003e — whether the technique uses ionizing radiation (X-rays), which carries a small long-term cancer risk, or uses no radiation at all\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003ePresence of artifacts\u003c\/strong\u003e — technical distortions or false signals in the images that can obscure details or lead to misreading\u003c\/li\u003e\n\u003c\/ul\u003e\n\n\u003cp\u003eThe authors argue that a detailed understanding of these trade-offs is \u003cstrong\u003ecrucial\u003c\/strong\u003e before any imaging technique is introduced into routine cardiovascular screening.\u003c\/p\u003e\n\n\u003ch2 id=\"key-findings\"\u003eKey Findings: Strengths and Weaknesses of Each Approach\u003c\/h2\u003e\n\n\u003cp\u003eWhile the full review details the specific strengths and weaknesses of each modality, the abstract makes clear that every approach involves a balance of competing factors. Here is a patient-friendly breakdown of how these trade-offs generally play out:\u003c\/p\u003e\n\n\u003cp\u003e\u003cstrong\u003eUltrasound\u003c\/strong\u003e is widely available, relatively low-cost, and completely free of ionizing radiation. It is non-invasive and portable, making it convenient for screening. However, ultrasound images can be limited by \u003cstrong\u003eartifacts\u003c\/strong\u003e — for example, calcium in the plaque can create shadowing that hides tissue behind it — and the technique is operator-dependent, meaning image quality relies on the skill of the person performing the scan.\u003c\/p\u003e\n\n\u003cp\u003e\u003cstrong\u003eComputed tomography (CT)\u003c\/strong\u003e provides excellent detail and is particularly useful for detecting and quantifying \u003cstrong\u003ecoronary artery calcium\u003c\/strong\u003e, a strong marker of plaque burden. CT scans are fast and highly reproducible. The main drawbacks are \u003cstrong\u003eradiation exposure\u003c\/strong\u003e and cost, as well as the need for contrast dye in some protocols, which can be problematic for patients with kidney disease or contrast allergies.\u003c\/p\u003e\n\n\u003cp\u003e\u003cstrong\u003eMagnetic resonance (MR)\u003c\/strong\u003e offers the best \u003cstrong\u003esoft-tissue resolution\u003c\/strong\u003e of the blood vessel wall, allowing researchers to see not just the size of a plaque but also its contents — including lipid pools, fibrous caps, and inflammation. MRI does not use ionizing radiation, making it attractive for repeated monitoring over time. The weaknesses include high cost, longer scan times, limited availability, and difficulty in patients with claustrophobia or certain implanted devices.\u003c\/p\u003e\n\n\u003cp\u003eThe central message is this: the \"best\" imaging technique depends entirely on the clinical scenario. A technique that is perfect for research might be impractical for routine screening, and a technique that is fast and cheap might lack the resolution to detect dangerous plaque features.\u003c\/p\u003e\n\n\u003ch2 id=\"microvascular\"\u003eMicrovascular Imaging: A New Frontier in Plaque Detection\u003c\/h2\u003e\n\n\u003cp\u003eOne of the most exciting areas covered in this review is \u003cstrong\u003emicrovascular imaging\u003c\/strong\u003e — the visualization of tiny blood vessels that grow inside the plaque itself. Recent research has shown that these small, fragile vessels play a major role in making plaque dangerous.\u003c\/p\u003e\n\n\u003cp\u003eHealthy artery walls contain tiny blood vessels called \u003cstrong\u003evasa vasorum\u003c\/strong\u003e that supply oxygen and nutrients to the vessel wall. In atherosclerosis, these microvessels can multiply abnormally and grow deep into the plaque. These new vessels are often leaky and weak, and their presence is associated with \u003cstrong\u003eplaque vulnerability\u003c\/strong\u003e — the tendency of a plaque to rupture and cause a heart attack or stroke.\u003c\/p\u003e\n\n\u003cp\u003eThe review highlights two advanced ultrasound-based techniques for seeing these microvessels:\u003c\/p\u003e\n\n\u003cul\u003e\n  \u003cli\u003e\n\u003cstrong\u003eContrast-enhanced ultrasound (CEUS)\u003c\/strong\u003e — This technique uses microbubble contrast agents, which are tiny gas-filled bubbles injected into the bloodstream. The bubbles circulate through the blood vessels and can be visualized with ultrasound, allowing researchers to detect and measure the density of microvessels within a plaque lesion.\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003eSuperb microvascular imaging (SMI)\u003c\/strong\u003e — A newer ultrasound technique that uses sophisticated signal-processing software to separate very slow blood flow signals from tissue motion artifacts. This allows visualization of tiny, low-flow vessels without the need for contrast agents.\u003c\/li\u003e\n\u003c\/ul\u003e\n\n\u003cp\u003eThese techniques represent a shift in how we think about atherosclerosis imaging. Instead of just asking \u003cem\u003ehow much plaque is there\u003c\/em\u003e, doctors may soon be able to ask \u003cem\u003ehow dangerous is this plaque?\u003c\/em\u003e The ability to detect blood vessels inside a plaque that may contribute to \u003cstrong\u003evulnerability and rupture\u003c\/strong\u003e could dramatically improve risk assessment.\u003c\/p\u003e\n\n\u003ch2 id=\"clinical-implications\"\u003eClinical Implications: What This Means for Patients\u003c\/h2\u003e\n\n\u003cp\u003eFor patients, the most important takeaway is that \u003cstrong\u003ecardiovascular screening is not one-size-fits-all\u003c\/strong\u003e. The choice of imaging technique involves a careful weighing of benefits and risks, and the review emphasizes that this evaluation must happen before any technique becomes part of routine screening.\u003c\/p\u003e\n\n\u003cp\u003eThis matters because a screening test that exposes patients to unnecessary radiation, cost, or invasive procedures without changing treatment decisions is not truly helpful. The strengths of each technique must justify its weaknesses in the specific population being screened.\u003c\/p\u003e\n\n\u003cp\u003eOn the positive side, advances in imaging mean that doctors are increasingly able to:\u003c\/p\u003e\n\u003cul\u003e\n  \u003cli\u003eDetect atherosclerosis \u003cstrong\u003ebefore symptoms develop\u003c\/strong\u003e\n\u003c\/li\u003e\n  \u003cli\u003eMeasure the total burden of disease across multiple vascular beds\u003c\/li\u003e\n  \u003cli\u003eIdentify \u003cstrong\u003ehigh-risk or vulnerable plaques\u003c\/strong\u003e that are more likely to rupture\u003c\/li\u003e\n  \u003cli\u003eMonitor whether treatments such as statins are actually reducing plaque burden over time\u003c\/li\u003e\n\u003c\/ul\u003e\n\n\u003cp\u003eThe review also discusses the future of advanced imaging modalities as \u003cstrong\u003epotential biomarkers\u003c\/strong\u003e. A biomarker is a measurable indicator of a biological condition. If imaging features — such as the density of microvessels inside a plaque — can reliably predict future heart attacks or strokes, they could become powerful tools for guiding treatment decisions. For example, a patient with a \"stable-looking\" plaque might be managed with lifestyle changes and medication, while a patient with a \"vulnerable\" plaque might be referred for more aggressive intervention.\u003c\/p\u003e\n\n\u003ch2 id=\"limitations\"\u003eLimitations of This Research\u003c\/h2\u003e\n\n\u003cp\u003eAs a narrative review, this article synthesizes existing evidence but does not itself include new patient data. This means the conclusions are only as strong as the underlying studies they are based on, and the quality of those studies varies across the field.\u003c\/p\u003e\n\n\u003cp\u003eThe authors also note, implicitly, that imaging technology is evolving rapidly. A technique that appears state-of-the-art today may be outdated in just a few years. The reproducibility and standardization of advanced techniques like CEUS and SMI are still being refined, and more research is needed to confirm that microvascular imaging findings truly translate into improved patient outcomes.\u003c\/p\u003e\n\n\u003cp\u003eFinally, the review does not provide specific recommendations for which imaging test every patient should receive. Instead, it emphasizes that the decision must be individualized, based on a patient's risk factors, symptoms, and the clinical question at hand. The promise of imaging-based biomarkers for atherosclerosis remains largely in the research and validation stage.\u003c\/p\u003e\n\n\u003ch2 id=\"recommendations\"\u003eRecommendations for Patients\u003c\/h2\u003e\n\n\u003cp\u003eWhile this article is a scientific review rather than a patient guideline, it offers several practical messages that patients can take to heart:\u003c\/p\u003e\n\n\u003col\u003e\n  \u003cli\u003e\n\u003cstrong\u003eTalk to your doctor about your cardiovascular risk.\u003c\/strong\u003e If you have risk factors such as high blood pressure, high cholesterol, diabetes, smoking history, or a family history of heart disease, you may benefit from vascular imaging. Ask whether a screening test is appropriate for you.\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003eAsk which imaging test is being recommended and why.\u003c\/strong\u003e Your doctor should be able to explain whether the test involves radiation, contrast dye, or any discomfort, and what information it will provide.\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003eUnderstand the trade-offs.\u003c\/strong\u003e An ultrasound is radiation-free and inexpensive but may not show as much detail. A CT scan gives excellent coronary calcium information but involves radiation. MRI offers the best soft-tissue detail but is costly and slower. There is no perfect test — only the right test for your situation.\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003eKnow the meaning of plaque burden and vulnerable plaque.\u003c\/strong\u003e The amount of plaque in your arteries matters, but so does the type of plaque. New imaging techniques are helping doctors identify plaques that are at high risk of rupturing, which is an important step toward preventing heart attacks and strokes.\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003eDon't forget prevention.\u003c\/strong\u003e Imaging is a powerful tool, but it cannot replace the fundamentals of cardiovascular health. A heart-healthy diet, regular physical activity, not smoking, managing blood pressure, cholesterol, and diabetes, and taking prescribed medications remain the cornerstone of preventing atherosclerosis and its complications.\u003c\/li\u003e\n\u003c\/ol\u003e\n\n\u003cp\u003eThe future of vascular imaging is bright. With continuing advances in microvascular imaging and the development of imaging-based biomarkers, doctors are moving closer to the goal of personalized cardiovascular care — detecting dangerous plaque early, treating it wisely, and preventing the life-changing events that atherosclerosis can cause.\u003c\/p\u003e\n\n\u003c!-- ddn:faq:start --\u003e\n\u003ch2 id=\"ddn-faq\"\u003eFrequently Asked Questions\u003c\/h2\u003e\n\u003ch3\u003eWhat is atherosclerosis and why is imaging used for it?\u003c\/h3\u003e\n\u003cp\u003eAtherosclerosis is a chronic inflammatory disease where fatty plaque builds up inside artery walls. It can lead to heart attacks, strokes, and poor circulation. Imaging helps doctors see plaque in arteries, measure how much is present, and sometimes assess whether plaque is dangerous or likely to rupture. It is used for early detection and monitoring.\u003c\/p\u003e\n\u003ch3\u003eDoes vascular imaging involve radiation?\u003c\/h3\u003e\n\u003cp\u003eCT scans use ionizing radiation, which carries a small long-term cancer risk. Ultrasound and magnetic resonance imaging do not use ionizing radiation. The choice of test depends on balancing the need for detail against radiation exposure, cost, and other factors. Your doctor can explain whether a specific test involves radiation and why it is recommended for you.\u003c\/p\u003e\n\u003ch3\u003eWhat is a vulnerable plaque and how can imaging detect it?\u003c\/h3\u003e\n\u003cp\u003eA vulnerable plaque is one that is more likely to rupture and cause a heart attack or stroke. New ultrasound techniques, like contrast-enhanced ultrasound and superb microvascular imaging, can detect tiny, fragile blood vessels that grow inside plaque. Their presence is associated with plaque vulnerability. This information may improve risk assessment beyond just measuring plaque size.\u003c\/p\u003e\n\u003ch3\u003eIs one imaging test better than another for everyone?\u003c\/h3\u003e\n\u003cp\u003eNo single technique is perfect for every situation. The choice depends on the clinical question, cost, radiation exposure, resolution, and patient factors. For example, ultrasound is radiation-free but operator-dependent, CT gives excellent coronary calcium detail but uses radiation, and MR offers high soft-tissue detail but is costly and slower. The right test depends on your individual circumstances.\u003c\/p\u003e\n\u003ch3\u003eCan imaging monitor whether my atherosclerosis treatment is working?\u003c\/h3\u003e\n\u003cp\u003eYes, imaging can be used to measure total plaque burden and monitor whether treatments such as statins are reducing it over time. MR imaging is attractive for repeated monitoring because it does not use ionizing radiation. However, the review notes that the reproducibility of advanced techniques is still being refined, and more research is needed to confirm long-term benefits.\u003c\/p\u003e\n\u003ch3\u003eShould I ask my doctor about vascular imaging for heart attack or stroke risk?\u003c\/h3\u003e\n\u003cp\u003eIf you have risk factors such as high blood pressure, high cholesterol, diabetes, smoking history, or a family history of heart disease, you may benefit from vascular imaging. Ask whether a screening test is appropriate for you, which test is recommended, and what it involves. Imaging does not replace prevention: a heart-healthy diet, exercise, not smoking, and managing risk factors remain essential.\u003c\/p\u003e\n\u003ch3\u003eWhen should a patient with atherosclerosis seek a second opinion about vascular imaging?\u003c\/h3\u003e\n\u003cp\u003eA second opinion can help because no single imaging test is perfect. Ultrasound is radiation-free and low-cost but operator-dependent and limited by artifacts like calcium shadowing. CT gives excellent coronary calcium detail but involves radiation and sometimes contrast dye. MRI offers excellent soft-tissue detail of plaque contents but is costly, slower, and unsuitable for some patients. Since the right test depends on your risk factors, symptoms, and the question being asked, a second opinion can clarify whether the recommended imaging is appropriate and whether results would change your treatment plan. Diagnostic Detectives Network provides independent expert second opinions.\u003c\/p\u003e\n\u003c!-- ddn:faq:end --\u003e\n\n\u003ch2 id=\"source\"\u003eSource Information\u003c\/h2\u003e\n\n\u003cp\u003e\u003cstrong\u003eOriginal article title:\u003c\/strong\u003e Abstract Vascular imaging of atherosclerosis- Strengths and weaknesses\u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eAuthors:\u003c\/strong\u003e Laura E. Mantella, Kiera Liblik, and Amer M. Johri\u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eAffiliations:\u003c\/strong\u003e Department of Biomedical and Molecular Sciences, Queen's University; Department of Medicine, Cardiovascular Imaging Network at Queen's University, Kingston, Ontario, Canada\u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eJournal:\u003c\/strong\u003e \u003cem\u003eAtherosclerosis\u003c\/em\u003e, February 2021, Volume 319, pages 42–50\u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003ePublication details:\u003c\/strong\u003e Published online January 6, 2021 | DOI: 10.1016\/j.atherosclerosis.2020.12.021 | PMID: 33476943\u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eKeywords:\u003c\/strong\u003e Atherosclerosis; Computed tomography; Imaging; Magnetic resonance; Ultrasound; Vascular\u003c\/p\u003e\n\u003cp\u003eThis patient-friendly article is based on peer-reviewed research and is intended for educational purposes. It does not replace professional medical advice. Always consult your healthcare provider for guidance about screening, diagnosis, and treatment.\u003c\/p\u003e","brand":"DiagnosticDetectives.Com","offers":[{"title":"Default Title","offer_id":47471120253084,"sku":null,"price":0.0,"currency_code":"USD","in_stock":true}],"url":"https:\/\/diagnosticdetectives.com\/de\/products\/seeing-inside-your-arteries-the-strengths-and-weaknesses-of-vascular-imaging-for-atherosclerosis","provider":"DiagnosticDetectives.Com","version":"1.0","type":"link"}